Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor designed to address the core symptoms of ADHD in children and adults.

Fiona Edwards is 50 years old, but to this day, some of her most traumatic memories are from her elementary school classroom in the Caribbean. As a child with an overactive imagination who struggled ...

Thirty years ago, medical and psychological experts believed attention deficit hyperactivity disorder (ADHD) was a childhood disease. Clinicians reassured parents that their child would outgrow the ...

Hundreds of studies are published each year on attention deficit hyperactivity disorder (ADHD), but more work is needed to ensure those findings improve lives. With input from expert stakeholders ...

Antibiotics still overused in bronchitis, sore throats Variation signals disparity between clinical practice guidelines and actual practice. HealthDay News — There ...

In an updated clinical guideline on attention-deficit/hyperactivity disorder (ADHD), the American Academy of Pediatrics (AAP) stresses the need for ongoing team-based ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.

More people with attention-deficit/hyperactivity disorder (ADHD) are turning to coaches for guidance. Those coaches, who ...

While safe, external trigeminal nerve stimulation does not show clinical efficacy for ADHD in children and adolescents.